Leadership

Mr. Donghoon Lee is the Chief Executive Officer and President of SK Biopharmaceuticals and its U.S. subsidiaries SK Life Science, Inc. and SK Life Science Labs. His vision is to transform all three companies so that together they become a global biotech leader while generating synergy with SK Group, its affiliates, and partners. Previously, Mr. […]

Matt Linkewich joined SK Life Science, Inc. as a founding member of the commercial team, assuming the role of Chief Commercial Officer in 2021. With nearly three decades of experience in the emerging biotech and pharmaceutical sector, Matt spearheads the commercialization endeavors for SK Life Science.

Sunita Misra, MD, PhD joined the SK Life Science, Inc. team in 2023 initially supporting the ongoing clinical studies. Her deep experience as a clinician and researcher in pediatric epilepsy has enabled Dr. Misra to guide the organization’s clinical development strategy.

As the Vice President and Global Head of Regulatory Affairs at SK Life Science, Darshan brings a wealth of knowledge and experience to our leadership team. During his 20 years in the pharmaceutical industry, Darshan has led several regulatory affairs and pharmacovigilance teams at various pharmaceutical companies, concentrating on the development of treatments for CNS and cardiovascular disorders.

Hina Patel joined SK Life Science, Inc. as Vice President and Global Head of Quality Assurance and Document Management in 2011. With nearly three decades of experience in research and development and commercial quality, Hina has demonstrated expertise and knowledge in navigating the complex landscape of regulatory compliance, and drug development.

Josh McLaughlin joined SK Life Science, Inc. in 2020 and is the Company’s General Counsel and Head of Legal and Compliance. With a deep knowledge of the industry and strong history of legal leadership, Josh plays a critical role in guiding our organization’s legal strategy and ensuring compliance across all aspects of our operations.

Changho Yu joined SK Biopharmaceuticals Co., Ltd., and its subsidiary, SK Life Science, in 2002. During his 20-year tenure, Mr. Yu has become an integral leader who brings a wealth of knowledge and experience to the Strategy and Investment business function.

Jason Kim is a seasoned financial executive with a diverse background spanning strategic finance, investment management, and corporate leadership. Currently serving as VP, Corporate Center, Jason oversees Human Resources and Information Technology at SK Life Science, Inc. ensuring streamlined operations across the board.

Mike Polito joined SK Life Science, Inc. in 2019 and is currently the VP, Head of Finance. With a career in finance spanning over 30 years, Mike brings immense accounting and finance acumen and analytical skills to SK Life Science, Inc. to help lead its finance and accounting team.

Kiel Kim is a Vice President, Global Business Development of SK Life Science Inc. as well as the Chief Business Officer, Chief Operating Officer, and board member of SK Life Science Labs. He is responsible for executing the vision of growing SK Life Science Labs into a global biotech company. Previously, Mr. Kim was the […]

Keun Yong “Austin” Cho brings a wealth of expertise to SK Life Science as Vice President of Commercial. 

Jaclyn Ancora joined SK Life Science, Inc. in 2019 and is the SKLSI Executive Director, Human Resources. She and her team are focused on delivering a strategy that focuses on individual career growth while maintaining the needs of the business, ensuring that the HR team’s initiatives are aligned with the Company’s goals and core values. […]

Christine Stuhlmiller joined SK Life Science in 2024 as Executive Director for Program Management. Christine brings a deep knowledge of project execution that spans the breadth of drug development, from Discovery through Commercialization, and she plays a key role in ensuring communication, risk identification, and alignment for development projects.

Chris Lee joined SK Life Science Inc. in May 2025 as Executive Director, Head of CMC and Clinical Supply. He brings over 20 years of experience in CMC development and commercialization within the biopharmaceutical industry.